Author: Mike

  • FNGR Up 136.7% at Peak, Still Holding 96.7% Into the Afternoon

    Dear Reader,

    One from this morning’s watchlist is having a big day.

    FingerMotion, Inc. (Nasdaq: FNGR) opened at $0.30 and shot up to a high of $0.71 by 10:00 a.m., a potential gain of 136.7% for those who caught the top. It has pulled back some but is still trading at $0.59, up 96.7% from the open. Hopefully you were able to get in early on this one.

    Keep a close eye on FNGR through the rest of the afternoon.

    More updates coming.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. We have not been compensated for this email.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • 3 Small Caps Worth Watching Before the Open Today

    Dear Reader,

    It’s the final trading day of the week…and as usual, the action has already started before the opening bell.

    A few small cap Nasdaq stocks are showing early momentum in pre-market trading, and they’re worth keeping an eye on as we head into Friday’s session:

    * Aethlon Medical, Inc. (Nasdaq: AEMD) gaining 28.6% ahead of the open

    * Wheeler Real Estate Investment Trust, Inc. (Nasdaq: WHLR) – up 29.5% pre-market

    * FingerMotion, Inc. (Nasdaq: FNGR) – leading early movers, up 61.9%.

    Not every early mover will hold its gains, but this is often where the day’s most active setups begin.

    I’m also watching a potential breakout play developing now. If it confirms, you’ll get the details in my next Breakout Alert.

    Have a great Friday,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. We have not been compensated for this email.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • NMTC Jumped 62.3% After This Morning’s Alert

    Dear Reader,

    Today’s Breakout Alert on NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) moved fast.

    The stock was trading at $2.15 when our alert went out and jumped to $3.49 by 10:00 a.m. That’s a gain of 62.3% in a little more than an hour for those who were ready to act. Hope you were able to ride that wave.

    Tomorrow morning’s pre-market watchlist hits your inbox at the usual time with three fresh small cap names showing early strength before the bell.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. NeuroOne Medical Technologies Corporation has paid or will pay Publisher up to one hundred thousand dollars for marketing services including communicating information about the (NASDAQ:NMTC) to the Public. This advertorial (“advertisement” or “Advertorial”) is part of those issuer-paid marketing services. The marketing services are anticipated to last one month, however, the term of the services could be extended or it could be terminated earlier.  As a result of this advertisement and other marketing efforts, Publisher also may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Publisher holds no securities of the (NASDAQ:NMTC) and does not intend to purchase any securiies during the Term. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of (NASDAQ:NMTC), increased trading volume, and possibly an increased share price of the (NASDAQ:NMTC) securities, which may or may not be temporary and decrease once the marketing services have ended.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • 🚀 NMTC Up 47% Since This Morning’s Alert

    Good morning readers,

    We flagged NMTC (Nasdaq: NMTC) at $2.15 this morning at 8:55 AM ET — and it’s already hit a high of $3.16, a gain of roughly 47%.

    Adding fuel to the move: NeuroOne Medical Technologies just announced the successful completion of three large-animal procedures using its next-generation StereoCED™ platform. The company reported that in two of the three procedures, its drug delivery electrodes both delivered a study agent directly into targeted brain tissue and recorded intracranial electrophysiological activity from the same region — something NeuroOne says hasn’t been previously demonstrated. The results build momentum toward the company’s planned launch of StereoCED™ for human investigational clinical studies later this quarter.

    We’ll continue watching NMTC closely as the day develops.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. NeuroOne Medical Technologies Corporation has paid or will pay Publisher up to one hundred thousand dollars for marketing services including communicating information about the (NASDAQ:NMTC) to the Public. This advertorial (“advertisement” or “Advertorial”) is part of those issuer-paid marketing services. The marketing services are anticipated to last one month, however, the term of the services could be extended or it could be terminated earlier.  As a result of this advertisement and other marketing efforts, Publisher also may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Publisher holds no securities of the (NASDAQ:NMTC) and does not intend to purchase any securiies during the Term. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of (NASDAQ:NMTC), increased trading volume, and possibly an increased share price of the (NASDAQ:NMTC) securities, which may or may not be temporary and decrease once the marketing services have ended.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • Today’s Alert: NMTC

    Good morning readers,

    Today’s breakout alert is NASDAQ:NMTC. 

    NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is a medical technology company focused on improving surgical care for patients with neurological disorders. The company has four FDA-cleared products on the market, including the only device of its kind cleared for brain ablation procedures.

    Physicians at Mayo Clinic in Jacksonville, Florida recently reported their experience using the OneRF system in 25 patients with drug-resistant epilepsy, describing the procedures as well tolerated with reduced seizure frequency and improved quality of life.

    The company is also collaborating with Mayo Clinic on a funded research program targeting pediatric brain cancer using its drug delivery technology.

    NMTC currently trades around $2 with a market cap under $20 million, while analyst price targets sit well above the current level. The stock has traded as high as $6.96 in the past year.

    This is a company with FDA-cleared products…real clinical adoption…and a price point that’s fallen well off its highs. Keep a close eye on this one today.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. NeuroOne Medical Technologies Corporation has paid or will pay Publisher up to one hundred thousand dollars for marketing services including communicating information about (NASDAQ:NMTC) to the Public. This advertorial (“advertisement” or “Advertorial”) is part of those issuer-paid marketing services. The marketing services are anticipated to last one month, however, the term of the services could be extended or it could be terminated earlier.  As a result of this advertisement and other marketing efforts, Publisher also may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Publisher holds no securities of the (NASDAQ:NMTC) and does not intend to purchase any securiies during the Term. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of (NASDAQ:NMTC), increased trading volume, and possibly an increased share price of the (NASDAQ:NMTC) securities, which may or may not be temporary and decrease once the marketing services have ended.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • Watch Your Inbox: Breakout Alert Coming in 90 Minutes

    Dear Reader,

    Before the trading day gets started, a quick reminder:

    A new Breakout Alert hits your inbox at 9:00AM ET. This one is a small cap medical technology company with FDA-cleared products already on the market, a Mayo Clinic collaboration and a stock trading well off its highs.

    Keep your inbox open and be ready to move when it arrives.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. We have not been compensated for this email.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • CRE Moved 40.8% + New Breakout Alert Tomorrow 9 AM

    Dear Reader,

    Wednesday’s biggest window came early. CRE jumped 40.8% in the first two hours of trading, giving those who were watching from the open a solid opportunity before the stock settled back.

    Now for tomorrow…

    A new Breakout Alert drops at 9:00 a.m. eastern. Make sure you’re at your screen and ready to move when it hits your inbox.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. We have not been compensated for this email.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • CRE Hit 40.8% Early: Both CRE and YYGH Still Worth Watching

    Dear Reader,

    Two stocks from this morning’s watchlist are worth keeping on your screen this afternoon.

    CRE made the bigger move, jumping 40.8% in the first two hours of trading and giving a nice window to those who caught the top. It has pulled back from that high but is still trading slightly above its open price.

    YYGH is also holding just above its open, which is worth noting on a day when the broader market has been mixed.

    Both remain in play as the afternoon unfolds. Keep a close eye on each of them.

    More updates coming.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. We have not been compensated for this email.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • Today’s Pre-Market Scan: 3 Names Standing Out  

    Dear Reader,

    We’re at mid-week and three small cap Nasdaq names have already surfaced in this morning’s pre-market scan.

    Here’s what’s worth watching before the bell:

    * CID HoldCo, Inc. (Nasdaq: DAIC) – advancing 51.3% in pre-market trading

    * YY Group Holding Limited (Nasdaq: YYGH) – climbing 68.7% ahead of the open

    * Cre8 Enterprise Limited (Nasdaq: CRE) – gaining an impressive 152.8% on solid early volume.

    Tuesday was a solid session for the Nasdaq. When the broader market has some wind at its back, small caps often follow. These three are worth a close look as the session gets underway.

    Also on the radar: a small cap that’s been setting up quietly. If it breaks the right way, a Breakout Alert will be in your inbox shortly after.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. We have not been compensated for this email.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.

  • RIME’s Early Move + Fresh Watchlist Tomorrow

    Dear Reader,

    A quick wrap on today’s Breakout Alert.

    Algorhythm Holdings, Inc. (Nasdaq: RIME) was trading at $0.34 when our alert went out this morning and ran to $0.42 shortly after. The afternoon never produced a second move, but the early window was there for those who acted quickly.

    Wednesday’s pre-market watchlist hits your inbox first thing tomorrow morning with three fresh small cap names showing early strength before the bell.

    Best,

    Mike

    Important Notice and DISCLAIMER

    To more fully understand any subscription, website, application, product, or other service (“Services”) including Stocks by Mike, please review our full disclaimer and other policies located at stocksbymike.com/disclaimer.

    Issuer-paid Advertisement. Algorhythm Holdings has paid or will pay Publisher up to fifty thousand dollars for marketing services including communicating information about (NASDAQ:RIME) to the Public. This advertorial (“advertisement” or “Advertorial”) is part of those issuer-paid marketing services. The marketing services are anticipated to last one month, however, the term of the services could be extended or it could be terminated earlier.  As a result of this advertisement and other marketing efforts, Publisher also may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Publisher holds no securities of the (NASDAQ:RIME) and does not intend to purchase any securiies during the Term. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of (NASDAQ:RIME), increased trading volume, and possibly an increased share price of the (NASDAQ:RIME) securities, which may or may not be temporary and decrease once the marketing services have ended.

    For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position.  This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

    SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

    Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

    USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

    TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.